The clearance of MRD did not differ according to mutated status of TET1/2, IDH1/2, DNMT3A, MDS‐related genes, FLT3‐TKD and GATA2 (Figure 3C,D). This evidence concerns the gene FLT3 and myelodysplastic syndrome.